Patents Assigned to PRISM Biolab Corporation
  • ALPHA HELIX MIMETIC COMPOSITIONS FOR TREATING CANCER AND OTHER CBP/CATENIN-MEDIATED DISEASES AND CONDITIONS
    Publication number: 20140221657
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Application
    Filed: April 7, 2014
    Publication date: August 7, 2014
    Applicant: PRISM BioLab Corporation
    Inventors: Hiroyuki Kouji, Yuji Kogami, Takenao Odagami
  • Alpha helix mimetic compositions for treating cancer and other CBP/catenin-mediated diseases and conditions
    Patent number: 8691819
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Grant
    Filed: October 14, 2009
    Date of Patent: April 8, 2014
    Assignee: PRISM BioLab Corporation
    Inventors: Hiroyuki Kouji, Yuji Kogami, Takenao Odagami
  • Alpha helix mimetics and methods relating thereto
    Patent number: 8455488
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Grant
    Filed: June 5, 2009
    Date of Patent: June 4, 2013
    Assignee: PRISM BioLab Corporation
    Inventors: Takenao Odagami, Yuji Kogami, Hiroyuki Kouji
  • ALPHA HELIX MIMETICS AND METHODS RELATING THERETO
    Publication number: 20120088770
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a chemical library relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Application
    Filed: May 7, 2010
    Publication date: April 12, 2012
    Applicant: Prism BioLab Corporation
    Inventors: Takenao Odagami, Yiji Kogami, Hiroyuki Kouji
  • ALPHA HELIX MIMETICS IN THE TREATMENT OF CANCER
    Publication number: 20110263607
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Application
    Filed: October 14, 2009
    Publication date: October 27, 2011
    Applicant: PRISM BIOLAB CORPORATION
    Inventors: Hiroyuki Kouji, Yuji Kogami, Takenao Odagami
  • ALPHA HELIX MIMETICS AND METHODS RELATING THERETO
    Publication number: 20110092459
    Abstract: Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.
    Type: Application
    Filed: June 5, 2009
    Publication date: April 21, 2011
    Applicant: PRISM Biolab Corporation
    Inventors: Takenao Odagami, Yuji Kogami, Hiroyuki Kouji